Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Based on the post hoc analysis of the initial Phase 2a and 3a trials ... also be used to treat retina damage in patients with diabetic retinopathy, with already sufficient preclinical and clinical ...

Above 60: Annual check-ups are a mustâ even if there are no visible issuesâ because conditions like glaucoma, diabetic retinopathy, and macular degeneration often progress without early symptoms.

1 Nevertheless, even in patients with mild metabolic dysfunction, T2DM has serious long-term consequences (ie, nephropathy, neuropathy and retinopathy ... 7 Notably, screening for diabetic renal and ...

At ARVO 2025, in Salt Lake City, Utah, David Almeida, MD, MBA, PhD, talked about 12-month results from the PAVIA phase 2 ...

In patients with diabetic retinopathy, obstructive sleep apnea increases the risk for proliferative diabetic retinopathy, intravitreal injection, and stroke.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The following is a summary of “Exploring leukocyte differential count ratio profiles as inflammatory biomarkers in diabetic retinopathy: a systematic review and meta-analysis,” published in the May ...

Scientists say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier, an important boundary that regulates the flow of nutrients, waste and ...

Researchers found that higher urinary levels of caffeine and specific metabolites, especially in men, were significantly ...

The results highlight the therapeutic potential of melanocortin agonists PL9654 and PL9655 in treating diabetic retinopathy (DR). These compounds demonstrated strong anti-inflammatory effects ...